☰
HomeLiving Beyond BordersGZERO WorldSignalIn 60 SecondsPuppet RegimeGZERO World PodcastContact UsAbout UsCareersPrivacy PolicyTerms

After COVID vaccines, time to use mRNA tech against other infectious diseases

March 12, 2022
GZERO Staff
After COVID Vaccines, Time to Use mRNA Tech Against Other Infectious Diseases | GZERO Media

youtu.be

Using mRNA technology to develop effective COVID vaccines has been a scientific breakthrough.

But that's just the tip of the iceberg, Melanie Saville, head of vaccine development at the Coalition for Epidemic Preparedness Innovations, said during a livestream discussion on equitable vaccine distribution hosted by GZERO Media in partnership with the Bill & Melinda Gates Foundation. "

There's still a lot that should be done with the technology moving forward" on other infectious diseases like HIV, malaria, or TB. Still, she said that vaccines are only the beginning.

Local manufacturing and distribution is as important — as is future equitable access to the mRNA tech itself.

From Your Site Articles

More from GZERO Media

Deputy Head of Content

GZERO Media is seeking a Deputy Head of Content to create and manage daily content offerings including our newsletters, breaking news updates for social channels, digital video, podcasts, and branded content as needed. This role reports directly to the Chief Content Officer and will be responsible for writing, editing, and creating content as well as overseeing the work of reporters and creators. This position is based in our New York City global headquarters.

Canada faces a choice between the US and China

Then-Bank of England Governor Mark Carney shakes hands with then-Chinese Premier Li Keqiang before the 1+6 Round Table Dialogue meeting at the Diaoyutai State Guesthouse, in Beijing, China, on September 12, 2017.
REUTERS/Etienne Oliveau/Pool

Questions lurk over how Mark Carney plans to engage with China, as the United States warns allies against dealing with Beijing.

About UsCareers PressContact Us Privacy PolicyTerms of Use
© 2025 GZERO Media. All Rights Reserved | A Eurasia Group media company.